Overview:
Older adults are majorly benefited with home healthcare as it helps them to stay independently for as long as possible in an injury or illness. Home healthcare covers a broad range of services and can possess capability of delaying the need for long-term nursing home care. According to market experts, in the U.S. currently 12 million patients and more than 428 million patient visits each year out of which 70% are using home healthcare services aged 65 and older. The age group beyond 65 years affects with the most common conditions such as heart disease, diabetes and cerebral vascular diseases. On the basis of device type the home healthcare market is segmented as therapeutic devices, diagnostic and screening devices, home mobility assistance devices and medical supplies/ consumables. Furthermore, the diagnostic and screening devices segment comprises, heart rate monitors, blood pressure monitors, temperature monitors, pregnancy test kits, pedometers and coagulation monitors, pulse oximeters, sleep apnea monitors, and blood glucose monitors. The therapeutic devices segment is further segmented into ventilators, insulin delivery devices, nebulizers, and CPAP devices, IV equipment and dialysis equipment. The home mobility assistance devices segment is sub-segmented as cranes, wheelchairs, and crutches and other mobility assist devices. On the basis of services home healthcare market is segmented as telehealth services, respiratory therapy services, rehabilitation services, infusion therapy services, and unskilled home healthcare services.
The home healthcare market is driven by aging population, rising incidences of chronic diseases, increasing healthcare costs are fueling the demand for affordable healthcare delivery systems, technological advancements, and government supportive measures to ensure promotion of home healthcare. Moreover, patient safety concerns, altering reimbursement policies, and partial insurance coverage are major factors restricting the growth of this market. North America is anticipated to dominate the global home healthcare market due to encouraging reimbursement policies along with existence of large number of small and large scale healthcare service providers in the region stimulates the growth of home healthcare market. Europe was observed as the second largest home healthcare market after North America. The key factors responsible for growth of Europe home healthcare market are high prevalence of lifestyle diseases such as cardiovascular diseases and diabetes and rising healthcare investments by the government supports the growth of home healthcare market. Asia-Pacific home healthcare market is expected to grow at the highest CAGR during the forecast period 2016 to 2022. Rising healthcare expenditure, developing healthcare infrastructure, increasing public awareness associated with the diagnosis of lifestyle diseases and disposable income.
The global home healthcare market is segmented on the following bases:
1. Type of Device
a. Diagnostic and Screening Devices
i. Blood Glucose Monitors
ii. Heart Rate Monitors
iii. Sleep Apnea Monitors
iv. Pregnancy Test Kits
v. Pulse Oximeter
vi. Blood Pressure Monitors
vii. Temperature Monitors
viii. Coagulation Monitors
ix. Pedometers
b. Therapeutics Home Healthcare Devices
i. Nebulizers
ii. Insulin Delivery Devices
iii. Ventilator and Continuous Positive Airway Pressure (CPAP) Devices
iv. Intravenous (IV) Equipment
v. Dialysis Equipment
c. Home Mobility Assistance Devices
i. Cranes and Crutches
ii. Wheelchairs
iii. Other Home Mobility Assist Devices (Rollators, Walkers, and Mobility Scooters)
d. Medical Consumables
2. Type of Services
a. Telehealth Services
b. Respiratory Therapy Services
c. Infusion Therapy Services
d. Rehabilitation Services
e. Unskilled Home Healthcare Services
3. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key Players Identified for Home Healthcare Market Include but are Not Limited to:
F. Hoffmann-La Roche Ltd, Bayer Healthcare, ResMed, Inc., Omron Healthcare, Inc., Cardinal Health, Teleflex Corporation, Johnson & Johnson, Abbott Laboratories, Gentiva Health Services, Inc., Phillips Healthcare, Medtronic, Inc, Praxair Technologies, Inc., GE Healthcare, Invacare Corporation, and others.
This report offers:
